Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors

NCT00074321 ·Status: COMPLETED ·Phase: PHASE1

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

NCT01336842 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

NCT01460537 ·Status: COMPLETED ·Phase: PHASE1

Phase I Combination Ixabepilone + Cisplatin

NCT00832117 ·Status: COMPLETED ·Phase: PHASE1

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

NCT00251407 ·Status: COMPLETED ·Phase: PHASE1

Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer

NCT00907504 ·Status: WITHDRAWN ·Phase: PHASE3

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT00047047 ·Status: COMPLETED ·Phase: PHASE1

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00030576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00010023 ·Status: COMPLETED ·Phase: PHASE1

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

NCT00191620 ·Status: COMPLETED ·Phase: PHASE2

Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor

NCT00005839 ·Status: COMPLETED ·Phase: PHASE1

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

NCT00683514 ·Status: COMPLETED ·Phase: PHASE3

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

NCT00423865 ·Status: COMPLETED ·Phase: PHASE1

Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

NCT07046650 ·Status: RECRUITING ·Phase: PHASE2

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

NCT00004090 ·Status: COMPLETED ·Phase: PHASE1

Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery

NCT01093092 ·Status: TERMINATED ·Phase: PHASE1

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

NCT00003108 ·Status: COMPLETED ·Phase: PHASE1

Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies

NCT02620839 ·Status: TERMINATED ·Phase: PHASE1

Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan

NCT00249977 ·Status: COMPLETED ·Phase: PHASE1

A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

NCT00794417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour

NCT00778128 ·Status: COMPLETED ·Phase: PHASE1

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

NCT00573690 ·Status: COMPLETED ·Phase: PHASE1

A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

NCT00439426 ·Status: COMPLETED ·Phase: PHASE2

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC

NCT00191126 ·Status: COMPLETED ·Phase: PHASE3

Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin

NCT00611962 ·Status: COMPLETED ·Phase: PHASE2